The significance of Wfdc12 up-regulation in the DSS- and TSR-treated mice (Figure S3C), lies in the fact that an altered microbiota composition in the intestinal tract characterizes the pathogenesis of IBD [42], [43]. This evidence concerns the gene WFDC12 and inflammatory bowel disease.